Breaking News Instant updates and real-time market news.

RARE

Ultragenyx

$72.08

-0.74 (-1.02%)

08:36
04/16/19
04/16
08:36
04/16/19
08:36

Ultragenyx receives fast track designation for UX007 from FDA

Ultragenyx announced that the FDA has granted fast track designation and rare pediatric disease designation to UX007 for the treatment of long-chain fatty acid oxidation disorders, a group of genetic disorders in which the body is unable to convert long-chain fatty acids into energy.

  • 17

    Apr

  • 06

    May

RARE Ultragenyx
$72.08

-0.74 (-1.02%)

02/25/19
COWN
02/25/19
NO CHANGE
Target $69
COWN
Outperform
Ultragenyx coverage transferred with an Outperform at Cowen
Cowen analyst Yaron Werber assumed coverage of Ultragenyx with an Outperform rating and $69 price target. The analyst cites the company's experienced management, a portfolio of 2 commercial drugs and the upside potential of a "deep gene therapy pipeline". Werber estimates that Crysvita in X-linked hypophosphatemia has the global sales potential to achieve over $2B and also sees its UX007 potentially launching in 2020, adding that the company's multiple data expected in 2019 should "boost investor interest".
02/26/19
PIPR
02/26/19
NO CHANGE
Target $75
PIPR
Overweight
Ultragenyx capital raise timing in-line with expectations, says Piper Jaffray
Piper Jaffray analyst Christopher Raymond views the timing of Ultragenyx's $250M follow-on offering as generally in-line with expectations. Combined with a $37.5M overallotment, the analyst estimates the deal could net the company $277M in proceeds. With the offering out of the way, an overhang on shares is removed, Raymond tells investors in a research note. He believes this "clears the way for a busy catalyst schedule," including data updates from gene therapy assets DTX301 and DTX401 by mid-year. The analyst continues to like the setup and remains a buyer of Ultragenyx with an Overweight rating and $75 price target.
03/27/19
MSCO
03/27/19
UPGRADE
MSCO
Overweight
Ultragenyx upgraded to Overweight from Equal Weight at Morgan Stanley
03/27/19
MSCO
03/27/19
UPGRADE
Target $83
MSCO
Overweight
Morgan Stanley upgrades Ultragenyx to Overweight on undervalued pipeline
Morgan Stanley analyst Jeffrey Hung upgraded Ultragenyx to Overweight from Equal Weight as he believes the market still undervalues its clinical pipeline. While he thinks the market has largely priced in Crysvita in X-linked hypophosphatemia, Hung is bullish on DTX401 and thinks UX007 is likely to become the company's third approved drug in 2020, he tells investors. Adding estimates for DTX401 to his model added $8 per share to his price target, noted Hung, who raised his target for Ultragenyx to $83 from $68 to account for that and other adjustments.

TODAY'S FREE FLY STORIES

EMES

Emerge Energy

$1.68

0.16 (10.53%)

16:53
04/22/19
04/22
16:53
04/22/19
16:53
Hot Stocks
Emerge Energy enters into a restructuring support agreement with its subsidiary »

Emerge Energy Services…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OMC

Omnicom

$81.83

-0.47 (-0.57%)

16:51
04/22/19
04/22
16:51
04/22/19
16:51
Hot Stocks
Omnicom officer Jonathan Nelson sells over $400K in company shares »

Omnicom officer Jonathan…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    May

CE

Celanese

$104.50

-0.7 (-0.67%)

16:50
04/22/19
04/22
16:50
04/22/19
16:50
Hot Stocks
Celanese reports Q1 EBIT $421M vs. $474M last year »

Reports Q1 operating…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

CE

Celanese

$104.50

-0.7 (-0.67%)

16:49
04/22/19
04/22
16:49
04/22/19
16:49
Hot Stocks
Celanese CEO sees Q2 conditions similar to Q1 »

CEO Mark Rohr says:…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

CE

Celanese

$104.50

-0.7 (-0.67%)

16:48
04/22/19
04/22
16:48
04/22/19
16:48
Earnings
Celanese backs FY19 EPS view of about $10.50, consensus $10.37 »

The company states:…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

CE

Celanese

$104.50

-0.7 (-0.67%)

16:46
04/22/19
04/22
16:46
04/22/19
16:46
Earnings
Celanese reports Q1 adjusted EPS $2.62, consensus $2.41 »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

SIMO

Silicon Motion

$42.15

-0.52 (-1.22%)

16:44
04/22/19
04/22
16:44
04/22/19
16:44
Downgrade
Silicon Motion rating change  »

Silicon Motion cut to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

  • 28

    May

TSLA

Tesla

$262.90

-10.35 (-3.79%)

16:42
04/22/19
04/22
16:42
04/22/19
16:42
Hot Stocks
Tesla CEO sees Robotaxis on the road in 2020 »

Says cost of Robotaxi…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Apr

  • 24

    Apr

16:39
04/22/19
04/22
16:39
04/22/19
16:39
Conference/Events
SunTrust gov't affairs analysts to hold an analyst/industry conference call »

Analysts hold an…

BA

Boeing

$375.02

-5 (-1.32%)

, TSLA

Tesla

$262.90

-10.35 (-3.79%)

16:38
04/22/19
04/22
16:38
04/22/19
16:38
On The Fly
Fly Intel: Wall Street's top stories for Monday »

The major averages were…

BA

Boeing

$375.02

-5 (-1.32%)

TSLA

Tesla

$262.90

-10.35 (-3.79%)

KMB

Kimberly-Clark

$130.24

6.76 (5.47%)

GWW

Grainger

$291.05

-17.215 (-5.58%)

SSNLF

Samsung

$0.00

(0.00%)

KEYW

KEYW

$11.16

3.31 (42.17%)

JEC

Jacobs Engineering

$78.69

1.755 (2.28%)

AKRX

Akorn

$2.98

0.21 (7.58%)

EAF

GrafTech

$12.35

-1.58 (-11.34%)

ISRG

Intuitive Surgical

$490.70

-37.34 (-7.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Apr

  • 22

    Apr

  • 22

    Apr

  • 22

    Apr

  • 24

    Apr

  • 24

    Apr

  • 25

    Apr

  • 29

    Apr

  • 29

    Apr

  • 01

    May

  • 01

    May

  • 01

    May

  • 02

    May

  • 03

    May

  • 06

    May

  • 07

    May

  • 07

    May

  • 09

    May

  • 20

    May

  • 29

    May

  • 05

    Jun

TSLA

Tesla

$262.90

-10.35 (-3.79%)

16:38
04/22/19
04/22
16:38
04/22/19
16:38
Hot Stocks
Tesla CEO sees Model S/3/X production of 10,000/wk in 2019 »

Sees reaching Model S,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Apr

  • 24

    Apr

LENS

Presbia

$0.56

-0.0034 (-0.61%)

16:38
04/22/19
04/22
16:38
04/22/19
16:38
Hot Stocks
Breaking Hot Stocks news story on Presbia »

Presbia trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALDR

Alder Biopharmaceuticals

$12.77

0.1 (0.79%)

16:36
04/22/19
04/22
16:36
04/22/19
16:36
Hot Stocks
Alder Biopharmaceuticals: FDA accepts for review the BLA for eptinezumab »

Alder BioPharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    May

GPC

Genuine Parts

$103.62

-1.84 (-1.74%)

16:33
04/22/19
04/22
16:33
04/22/19
16:33
Hot Stocks
Genuine Parts CEO Paul Donahue to also serve as board chairman »

Genuine Parts announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Apr

TSLA

Tesla

$262.90

-10.35 (-3.79%)

16:32
04/22/19
04/22
16:32
04/22/19
16:32
Hot Stocks
Tesla says Autopilot observes driver, pedestrian tendencies »

Says Autopilot uses…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Apr

  • 24

    Apr

HSTM

HealthStream

$27.23

0.11 (0.41%)

16:32
04/22/19
04/22
16:32
04/22/19
16:32
Earnings
HealthStream backs FY19 revenue view $251M-$258M, consensus $255.84M »

Raises FY19 CapEx view to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 28

    May

HSTM

HealthStream

$27.23

0.11 (0.41%)

16:31
04/22/19
04/22
16:31
04/22/19
16:31
Earnings
HealthStream reports Q1 EPS 15c, consensus 7c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 28

    May

RCKT

Rocket Pharmaceuticals

$17.78

0.91 (5.39%)

16:31
04/22/19
04/22
16:31
04/22/19
16:31
Initiation
Rocket Pharmaceuticals initiated  »

Rocket Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GES

Guess

$16.66

-0.41 (-2.40%)

16:30
04/22/19
04/22
16:30
04/22/19
16:30
Hot Stocks
Breaking Hot Stocks news story on Guess »

Guess down 3.9% at $16…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:30
04/22/19
04/22
16:30
04/22/19
16:30
Options
Preliminary option volume of 15.3M today »

Preliminary option volume…

GRTS

Gritstone Oncology

$14.57

0.86 (6.27%)

16:29
04/22/19
04/22
16:29
04/22/19
16:29
Syndicate
Gritstone Oncology files to sell 6.5M shares of common stock »

Goldman Sachs & Co.,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACC

American Campus

$46.47

-0.87 (-1.84%)

16:28
04/22/19
04/22
16:28
04/22/19
16:28
Earnings
American Campus reports Q1 FFO 69c, consensus 65c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 01

    May

GES

Guess

$16.66

-0.41 (-2.40%)

16:26
04/22/19
04/22
16:26
04/22/19
16:26
Hot Stocks
Guess to initiate $150M stock buyback »

Guess intends to initiate…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GES

Guess

$16.66

-0.41 (-2.40%)

16:26
04/22/19
04/22
16:26
04/22/19
16:26
Syndicate
Guess to offer $250M in convertible senior notes »

The company states the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RHE

Regional Health Properties

$2.26

1.17 (107.34%)

16:26
04/22/19
04/22
16:26
04/22/19
16:26
Hot Stocks
Regional Health Properties not in compliance with NYSE listing rules »

Regional Health…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.